Source | Topical eprinomectin (mg/kg body weight) | Cmax (ng/mL) | Tmax (day) | T1/2 (days) | AUClast (day*ng/mL) |
---|---|---|---|---|---|
Current Study 4 | 1.0 (n = 8a) | 6.20 (± 1.71) | 3.13 (± 2.99) | 6.40 (± 2.95) | 48.8 (± 19.2) |
[19] | 0.5 (n = 6b) | 2.22 (± 0.88) | 1.2 (± 0.4) | 5.4 (± 0.7) | 13.6 (± 4.8) |
1.0 (n = 6c) | 5.25 (± 2.7) | 1.5 (± 0.5) | 12.2 (± 5.8) | 33.7 (± 22.5) | |
[16] | 0.5 (n = 6d) | NRe | NR | NR | 56.0 (± 26.2) |
[18] | 0.5 (n = 6f) | 2.28 (± 0.41) | 3.17 (± 0.40) | 2.20 (± 0.34) | 16.2 (± 3.69) |
0.5 (n = 6g) | 2.30 (± 0.60) | 3.00 (± 0.45) | 1.85 (± 0.13) | 15.5 (± 3.67) |